Intractable myoclonic seizures in an allogeneic stem cell transplant recipient: A rare case of myoclonic epilepsy
- PMID: 26288756
- PMCID: PMC4536288
- DOI: 10.1016/j.ebcr.2015.06.005
Intractable myoclonic seizures in an allogeneic stem cell transplant recipient: A rare case of myoclonic epilepsy
Abstract
Introduction: Myoclonus may be a rare complication of stem cell transplant but has limited discussion in the scientific literature.
Case: We present a case of an acute myeloid leukemia survivor who developed refractory myoclonic epilepsy four years after graft versus host disease (GVHD) developed six days following matched unrelated allogeneic hematopoietic stem cell transplant.
Discussion: Graft versus host disease occurs in 30-50% of allogenic hematopoietic stem cell transplant patients and may cause pharmacoresistant myoclonic epilepsy; however, the mechanisms by which GVHD leads to recurrent myoclonic seizures are not well understood (Lee, 2005) [1]. The paucity of clinical reports of such manifestation makes it difficult to diagnose and effectively manage these patients.
Keywords: Allogeneic transplants; Epilepsy; GVHD; Myoclonus; Seizure.
Figures
References
-
- Aigner B., DW M Myoclonus: clinical significance and an approach to classification. AMA Arch Neurol. 1960;2:600–615. - PubMed
-
- Guerrini R., Parmeggiani L., Kaminska A., Dulac O. Myoclonic astatic epilepsy. Epileptic Syndr Infancy Child Adolesc. 2002;3:105–112.
-
- Taylor J.W., Schiff D. Blood Marrow Transpl. Handb. Springer; 2015. Neurologic complications; pp. 311–321.
-
- Kamble RT, Chang C-C, Sanchez S, Carrum G. Central nervous system graft-versus-host disease: report of two cases and literature review. vol. 39. 2007. http://dx.doi.org/10.1038/sj.bmt.1705540. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources